Nasal vaccines for COVID-19 offer hope and face hurdles
A squirt up the nose could reduce coronavirus transmission, but the vaccines have challenges to overcome.
Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A squirt up the nose could reduce coronavirus transmission, but the vaccines have challenges to overcome.
Altimmune (NASDAQ:ALT – Get Rating)‘s stock had its “buy” rating reiterated by research analysts at JMP Securities in a research report issued on Wednesday, TipRanks reports. They currently have a $22.00 price target on the stock. JMP Securities’ price target suggests a potential upside of 339.12% from the company’s previous close. Other analysts also recently […]
GAITHERSBURG, Md., May 16, 2022 -- Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the... | May 16, 2022
Altimmune (NASDAQ:ALT – Get Rating) had its price target lowered by equities research analysts at Guggenheim to $27.00 in a research report issued on Monday, Stock Target Advisor reports. The firm presently has a “na” rating on the stock. Guggenheim’s price target points to a potential upside of 461.33% from the company’s current price. Other […]
Wall Street analysts forecast that Altimmune, Inc. (NASDAQ:ALT – Get Rating) will announce earnings of ($0.57) per share for the current quarter, according to Zacks. Three analysts have made estimates for Altimmune’s earnings, with the highest EPS estimate coming in at ($0.43) and the lowest estimate coming in at ($0.70). Altimmune posted earnings of ($0.38) […]